CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020		13,914,731
Beginning balance at Dec. 31, 2020	$ 79,328,671	$ 1,375	$ 137,249,496	$ (57,125,635)	$ (796,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)		1,750,000
Issuance of common stock, net of issuance costs	114,087,891	$ 175	114,087,716
Stock-based compensation	$ 406,488		406,488
Shares issued for exercise/vesting of stock-based compensation awards (in shares)	18,906	13,356
Shares issued for exercise/vesting of stock-based compensation awards	$ 30,452		30,452
Net loss	(6,576,038)			(6,576,038)
Ending balance (in shares) at Mar. 31, 2021		15,678,087
Ending balance at Mar. 31, 2021	187,277,464	$ 1,550	251,774,152	(63,701,673)	(796,565)
Beginning balance (in shares) at Dec. 31, 2021		15,894,395
Beginning balance at Dec. 31, 2021	161,784,606	$ 1,589	255,131,836	(92,683,000)	(665,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)		2,012,500
Issuance of common stock, net of issuance costs	122,059,476	$ 201	122,059,275
Stock-based compensation	$ (85,908)		(85,908)
Shares issued for exercise/vesting of stock-based compensation awards (in shares)	15,000	22,631
Shares issued for exercise/vesting of stock-based compensation awards	$ 0	$ 3	(3)
Foreign currency translation adjustments	193,644				193,644
Net loss	(9,154,632)			(9,154,632)
Ending balance (in shares) at Mar. 31, 2022		17,929,526
Ending balance at Mar. 31, 2022	$ 274,797,186	$ 1,793	$ 377,105,200	$ (101,837,632)	$ (472,175)